Recent progress in nanoscale metal-organic frameworks for drug release and cancer therapy

  • Liangcan He
  • , Yuan Liu
  • , Joseph Lau
  • , Wenpei Fan
  • , Qunying Li
  • , Chao Zhang
  • , Pintong Huang*
  • , Xiaoyuan Chen
  • *Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Abstract

Nanoscale metal-organic frameworks (MOFs) have been widely used as controlled drug delivery vehicles and cancer therapy agents due to their intrinsic superior properties. Scientists have made remarkable achievements in the field of nanomedicine by using the MOFs and MOF-based multifunctional nanomaterials due to the easy synthesis into nanoscale and functionalization. In this review, we highlight the recent progress of nanoscale MOFs as drug delivery vehicles for cancer theranostics. We divide the discussion into three parts. The first and second parts focus on the drug delivery of unmodified MOF and modified MOFs, respectively, while the third part focuses on porphyrin MOFs as photosensitizers for photodynamic therapy. Finally, we conclude by identifying areas of research that we believe will propel the translation and application of MOFs.

Original languageEnglish
Pages (from-to)1343-1365
Number of pages23
JournalNanomedicine
Volume14
Issue number10
DOIs
StatePublished - 2019
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • in situ drug encapsulation
  • nanoscale metal-organic frameworks
  • photodynamic therapy
  • porphyrinic metal-organic frameworks
  • stimuli-responsive drug release

Fingerprint

Dive into the research topics of 'Recent progress in nanoscale metal-organic frameworks for drug release and cancer therapy'. Together they form a unique fingerprint.

Cite this